Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Dementia01:30

Dementia

96
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
96
Association Areas of the Cortex01:21

Association Areas of the Cortex

5.0K
Association areas are regions of the cerebral cortex that do not have a specific sensory or motor function. Instead, they integrate and interpret information from various sources to enable higher cognitive processes such as memory, learning, and decision-making. Some key association areas include the following:
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
5.0K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

163
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
163
Prosopagnosia01:24

Prosopagnosia

129
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
129
Role of Cerebellum and Prefrontal Cortex in Memory01:14

Role of Cerebellum and Prefrontal Cortex in Memory

369
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
369

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Lexical and clinical predictors of verbal fluency interword intervals preceding cognitive impairment.

Neuropsychologia·2026
Same author

Post-Processing Automatic Transcriptions with Machine Learning for Verbal Fluency Scoring.

Speech communication·2024
Same author

A comparison of techniques for deriving clustering and switching scores from verbal fluency word lists.

Frontiers in psychology·2022
Same author

Verbal fluency response times predict incident cognitive impairment.

Alzheimer's & dementia (Amsterdam, Netherlands)·2022
Same author

Novel verbal fluency scores and structural brain imaging for prediction of cognitive outcome in mild cognitive impairment.

Alzheimer's & dementia (Amsterdam, Netherlands)·2016
Same author

Storage costs and heuristics interact to produce patterns of aphasic sentence comprehension performance.

Frontiers in psychology·2012

相关实验视频

Updated: Jun 6, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.3K

在前性痴呆症.

David Glenn Clark

    Continuum (Minneapolis, Minn.)
    |December 2, 2024
    PubMed
    概括

    前性痴呆症 (FTD) 是一种复杂的大脑疾病,有三个核心综合征. 了解FTD病理,包括蛋白质变异和遗传变异,有助于诊断和治疗的发展.

    科学领域:

    • 神经科学是一个神经科学.
    • 遗传学 是一个遗传学.
    • 神经学 神经学

    背景情况:

    • 前性痴呆症 (FTD) 涵盖了多种不同的临床综合征,有三个核心类型:行为变体FTD,非流动性初级渐进性失语症和语义初级渐进性失语症.
    • 临床表现与特定的大脑网络参与相关.
    • 这种潜在的病理主要归因于三种蛋白质的失调:交易性反应DNA结合蛋白43 (TDP-43),MAPT和FUS.

    研究的目的:

    • 为了解前性痴呆症候群 (FTD) 提出一个简化框架.
    • 详细介绍与FTD相关的病理和遗传变异.
    • 为临床医生提供诊断和管理FTD的基础.

    主要方法:

    • 对FTD临床表现,病理学和遗传学当前知识的审查和综合.
    • 根据临床特征和潜在的病理生理学,将FTD分为三个核心综合征.
    • 讨论遗传因素,包括C9orf72,MAPT和GRN变异.

    主要成果:

    • FTD综合征可以广泛分为行为变体FTD和两种形式的初级渐进性失言症.
    • 在大多数FTD病例中,TDP-43,MAPT和FUS蛋白质都与FTD有关.
    • 在C9orf72,MAPT和GRN的遗传变异是FTD遗传性的重要贡献者,在超过10%的病例中发现.

    更多相关视频

    Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
    09:33

    Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

    Published on: July 28, 2013

    28.4K
    Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
    08:29

    Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

    Published on: December 18, 2016

    14.0K

    相关实验视频

    Last Updated: Jun 6, 2025

    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
    12:28

    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

    Published on: June 3, 2020

    17.3K
    Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
    09:33

    Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

    Published on: July 28, 2013

    28.4K
    Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
    08:29

    Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

    Published on: December 18, 2016

    14.0K

    结论:

    • 一个简化的框架有助于理解FTD的异质性.
    • 目前,还没有改变疾病的治疗方法,但针对遗传变异的临床试验正在进行中.
    • 生物标志物的进步对于加速开发FTD新药治疗方法至关重要.